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Conclusion: Recipients wilh CYA-HTN demonstrate a blunted vasodilatory
response to low level exercise. This finding may be due to impaired en-
dothelial function, chronotropic insufficiency. or deranged vascular compli-
ance which may contribule to a reduction in peak V02 and reduced exercise
tolerance.
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Arterial-Ventricular Elastance Uncoupling in
Hypertensive Cardiac Transplant Recipients is
Improved by Vasodilator Therapy
Jeffrey D. AleXIS. Michael A. Fifer. Charles A. Boucher. G. William Dec, Marc
J. Semigran. Massachusetts General Hospital and Harvard Medical School. Boston, MA
Baseline 91 ± 4
NTP 103 ± 4'
'p < 0.05
Conclusions: (1) Arterial-ventricular elastance uncoupling occurs in hyper-
tensive CTR. (2) Acute vasodilator therapy improves but does not normalize
arterial-ventricular coupling and LV efficiency.
Regional Strain and Wall Motion of the
Transplanted Left Ventricle in Pediatric Patients
Using Magnetic Resonance Tagging
Mary T. Donofrio, Bernard J. Clark. Claudio Ramaciotti, Marshall L. Jacobs.
Kenneth E. Fellows, Paul M. Weinberg, Mark A. Fogel. The Children's Hospital of
Philadelphia, Philadelphia, PA
Cardiac transplant recipients (CTR) on cyclosporine often develop systemic
arterial vasoconstriction and hypertension with limited exercise tolerance
despite normal LV systolic function. The lack of cardiac autonomic innerva-
tion may contribute to the presence of arterial-venlricular elastance uncou-
pling in this situation. To assess arterial-ventricular coupling in hypertensive
CTR. LV micromanometer pressure and simultaneous radionuclide volume
were measured at baseline and during nitroprusside (NTP) infusion titrated
to lower systolic pressure to :::::120 mmHg (dose: 96 ± 15 /Lg/min. mean
± SEM) in 10 hypertensive CTR (age 43 ± 4 years) 20 ± 4 months after
transplantation. Ventricular elastance (Ees ) was calculated from the slope of
the end-systolic pressure-volume relation (ESPVR) and arterial elastance (Ea)
from the ratio end-systolic pressure/stroke volume. Arterial-ventricular elas-
tance coupling was assessed as the ratio Ea/Ees . Ventricular efficiency (EFF)
is represented by the ratio stroke work/pressure volume area (PVA), where
PVA is the area circumscribed by the ESPVR. diastolic pressure-volume rela-
tion and the systolic pressure-volume trajectory.
The biomechanical properties of the transplanted left ventricle (LV) may not
be the same as the normal LV which is innervated. has not undergone is-
chemic arrest. and is not at risk for cellular rejection. Abnormal LV systolic tor-
sion has been noted during histologic rejection in adult transplant patients.
This has not been assessed in pediatric patients. We studied 8 transplant pa-
tients (ages 5.1 ± 3.7 years. 2.6 ± 1.2 years post-transplant) who underwent
9 magnetic resonance imaging studies using spatial modulation of magneti-
zation, a tissue tagging technique. to quantify regional wall motion and de-
formation. Imaging was done within 6 days of endomyocardial biopsy in 7
of 9 studies. Seven normal adults were imaged as controls. Magnetic tag-
ging was performed at 2 LV short axis levels. atrioventricular valve (AW) and
apex, through 12 phases in systole. Intersection points were tracked. and
regional wall motion and strain (using the 2-dimensional strain tensor) was
determined. The myocardium was divided into 4 anatomic regions (ventric-
ular septum. IW = inferior wall. PW = posterior wall. and SW = superior
wall) and subdivived further into endocardial and epicardial regions. Review
of 7 biopsy specimens revealed 2 with rejection (grade 1A and grade 2). Car-
diac catheterization demonslrated normal hemodynamics in all except the
patient with grade 2 rejection.
Seven of 8 patients had clockwise twist of the SW, IW, and/or PW. and
all had regions of no twist. Four patients had akinetic regions and 2 demon-
strated paradoxical motion of the ventricular septum. Controls had counter-
clockwise twist in all regions. In transplant patients, strain and strain het-
erogeneity were similar between the 4 regions at the AW and the apex. The
ralio of endocardial to epicardial strain was similar between all regions at the
AW, but not at the apex. Strain was not different between transplant patients
and controls for each region. Strain heterogeneity was different between the
2 groups at the SW of the AW, and at the ventricular septum of the AW and
apex. When comparing AW to apex. there was no difference in strain. or the
endocardial-to-epicardial strain ratio. between transplant patients and con-
trols for each region.
Conclusions: Pediatric transplant patients demonstrale regional wall mo-
tion abnormalities in the absence of rejection. Compared to controls, the
transplanted LV maintains normal strain in the presence of abnormal twist.
This may be a compensatory mechanism and may have clinical implications.
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A Prospective, Randomized Steroid-free
Maintenance Protocol In Heart Transplant
Recipients
Evan Loh, Alex Kartashov, Gilbert H. Mudge, Jr. Hasp of the Univ PA; Philadelphia,
PA; Brigham & Women's Hospital, Boston, MA
Immunosuppressive therapy for orthotopic heart transplant (OHT) recipients
should be tailored in an effort to minimize steroid-induced morbidity. Ac-
cordingly, to assess the feasibility of and to identify specific predictors of
successful steroid-withdrawal following OHT. we prospectively randomized
34 OHT recipients to cyclosporine/prednisone/azathioprine (CPA; n = 19) vs.
cyclosporine/azathioprine (CA; n = 15) maintenance therapy. Mean follow-
up was 1.6 ± 0.1 yr. No perioperative Iymphocytolytic induction therapy was
used. End-point comparisons between CPA and CA groups included the per-
cent of patients steroid-free at 1 yr, total rejection episodes (2: IHSLT lilA).
number of major infections. blood pressure. hypercholesterolemia and sur-
vival. Total ischemic time. pre-transplant diagnosis. recipient/donor age and
gender, and mean PRA levels were similar between the two groups. In the CA
group. the mean post-OHT time to steroid-free was 228 d (range 167-356 dl
with 9/15 (60%) maintained steroid-free at one-yr. Patients were considered
steroid-free failures if they experienced 2: 2 episodes of moderate-severe
rejection requiring augmentation of immunotherapy. No differences in the
number or duration of rejection episodes. major infections. systolic/diastolic
BP or total cholesterol were observed between the two groups. The univari-
ate predictors of successful steroid-withdrawal included: 1) male donor(p <
0.02); 2) older recipient age (58 ± 2 vs. 48 ± 3 yrs; p = 0.02); and 3) older
donor age (34 ± 6 vs. 21 ± 2 yrs; p < 0.06). No difference in 1 yr survival was
observed between the CPA vs CA groups. as determined by Kaplan-Meier
analysis.
Conclusion: Steroid-withdrawal following OHT is not associated with in-
creased morbidity and/or mortality. We believe that this data is of importance
for the future rational design of "individualized" immunosuppression follow-
ing OHI.
Cardiac transplant recipients often exhibit exercise limitations and a reduc-
tion in peak V02. To determine whether these abnormalities are secondary
to vascular dysfunction, a common condition in congestive heart failure. we
studied the effect of low level exercise on vascular hemodynamics in 19 heart
transplant (tx) recipients (mean 207 ± 187 days) with cyclosporine-induced
hypertension (CYA-HTN) and 5 healthy controls by measuring forearm blood
flow and echo-Doppler-derived stroke volume. Results follow:
Cyclosporine-induced Hypertension: Vascular
and Exercise Hemodynamics in Cardiac
Transplant Recipients
Richard V. Milani, Hector O. Ventura, Frank W. Smart, Carl J. Lavie.
Massimo Pagani, Daniella Lucini, Joseph P. Murgo. Ochsner Medical Institutions,
New Orleans, LA; CNR, Ospedale "L. Sacco, .. Universita Milano, Milan, Italy
heart Ix controls p
pulse, rest (bpm) 107 ± 9 84 ± 17 0.0004
pulse. exercise (bpm) 113 ± 10 137 ± 10 0.0001
%change 6%'" 63%1 0.0001
Stroke volume, rest (cc) 64.8 ± 12.1 80.2 ± 10.5 002
Stroke volume. exercise (ee) 717 ± 15.4 1018 ± 277 007
%change 11%t 27%t 0.06
Cardiac output, rest (Umin) 68±14 50 ± 1.1 0.02
Cardiac output, exercise (llmin) 8.2 ± 1.1 138 ± 32 0.006
%change 21%t 176%1 0.001
Total vascular resistance. rest (Woods' U) 16.2 ± 4.2 165 ± 35 NS
Total vascular resistance. exercise (Woods' Ul 143 ± 2.9 85±29 001
%change _12%t _48%t 0002
Forearm blood flow, rest (cc/min/l1 00 mil 3.7 ± 1.4 28 ± 0.8 NS
Forearm blood flow, exercise (cc/minl1100 mil 4.0 ± 1.4 6.3 ± 30 0.02
%change 8%t 125%t 0.005
Forearm vascular resistance. rest (U) 328 ± 14.2 31.4± 11.7 NS
Forearm vascular resistance, exercise (U) 31.1 ± 128 20.5 ± 87 009
%change -5%* _35%t 006
'p = NS. t P = 0.05, 'p < 0.01
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